CVS Health Corp [NYSE: CVS] plunged by -$0.21 during the normal trading session on while it closed the day at $49.37.
CVS Health Corp stock has also loss -10.71% of its value over the past 7 days. However, CVS stock has declined by -15.42% in the 3 months of the year. Over the past six months meanwhile, it has lost -18.02% and lost -37.47% year-on date.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for CVS stock reached $61.86 billion, with 1.26 billion shares outstanding and 1.26 billion shares in the current float. Compared to the average trading volume of 12.14M shares, CVS reached a trading volume of 16823310 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about CVS Health Corp [CVS]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $66.32 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 1.75. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Deutsche Bank have made an estimate for CVS Health Corp shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 03, 2024. While these analysts kept the previous recommendation, Wells Fargo raised their target price from $60 to $66. The new note on the price target was released on November 18, 2024, representing the official price target for CVS Health Corp stock. Previously, the target price had yet another raise from $63 to $82, while Barclays kept a Overweight rating on CVS stock. On October 04, 2024, analysts increased their price target for CVS shares from 59 to 85.
The Average True Range (ATR) for CVS Health Corp is set at 1.90, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.17. The Price to Book ratio for the last quarter was 0.83, with the Price to Cash per share for the same quarter was set at 7.78. Price to Free Cash Flow for CVS in the course of the last twelve months was 36.67 with Quick ratio for the last quarter at 0.59.
CVS stock trade performance evaluation
CVS Health Corp [CVS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -10.71. With this latest performance, CVS shares dropped by -9.03% in over the last four-week period, additionally sinking by -18.02% over the last 6 months – not to mention a drop of -34.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 29.43, with the RSI for the last a single of trading hit 21.68, and the three-weeks RSI is set at 34.13 for CVS Health Corp [CVS]. The present Moving Average for the last 50 days of trading for this stock 58.26, while it was recorded at 52.39 for the last single week of trading, and 61.54 for the last 200 days.
CVS Health Corp [CVS]: An insightful look at the core fundamentals
CVS Health Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.59 and a Current Ratio set at 0.80.
Earnings per share (EPS) analysis for CVS Health Corp [CVS] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corp go to -2.54%.
CVS Health Corp [CVS]: Institutional Ownership
There are presently around $82.84%, or 82.95%% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 116.35 million shares, which is approximately 9.2341%. BLACKROCK INC., holding 100.15 million shares of the stock with an approximate value of $$5.91 billion in CVS stocks shares; and BLACKROCK INC., currently with $$3.64 billion in CVS stock with ownership which is approximately 4.8955%.
